Losses of soil, water, organic carbon and nutrients caused by water erosion in different crops and natural savannah in the northern Amazon

Currently in Brazil, the main form of erosion is caused by the impact of raindrops on the soil surface, triggering the process of water erosion and causing serious damage to agricultural areas. This study evaluated losses of soil, water, organic carbon and nutrients in different cultures, bare soil and savanna under natural rain. The experimental design was completely randomized with five treatments (bare soil - BS, cowpea bean - CB, Brachiaria brizantha - BB, corn - CO and natural savanna – SN) with three replications; The treatment of bare soil (BS), followed by the treatment cultivated with cowpea bean (CB) showed higher losses of soil, water, organic carbon and nutrients; The highest losses of soil, water, organic carbon and nutrients in the treatment of bare soil (BS) occurred during the period of greatest erosivity; but for treatments CB, BB and CO, the highest losses occurred during the establishment of the crop, in view of the lower soil cover. Soils cultivated with Brachiaria brizantha - BB, corn - CO and in the Natural Savana - SN area were more efficient in reducing soil and water losses during all months evaluated. Plant cover produced by the (SN) treatment and by the (BB) and (CO) treatments acted to reduce the harmful effects of erosion, minimizing losses of nutrients and organic carbon. The soil should be well protected during periods when rainfall presents the highest values of erosivity index

JetStream atherectomy for the treatment of in-stent restenosis of the femoropopliteal segment: one-year results of the JET-ISR study

PURPOSE: To report the results of a study evaluating JetStream atherectomy for the treatment of in-stent restenosis (ISR). MATERIALS AND METHODS: The JetStream XC atherectomy device, a rotational cutter with aspiration capacity, was evaluated in a prospective, multicenter study (JET-ISR) of 60 patients (mean age 70.2±10.8 years; 40 men) with femoropopliteal ISR (ClinicalTrials.gov identifier NCT02730234). Lesion length was 19.9±13.5 cm; 33 (55%) were chronic total occlusions and 26 (45%) were TransAtlantic Inter-Society Consensus class D. No drug-bearing device was allowed, and stenting was performed only for bailout. Lesion characteristics and stent integrity were evaluated by an independent core laboratory. The primary endpoint was target lesion revascularization (TLR) at 6 months with bailout stenting considered as TLR. Secondary endpoints included TLR (without bailout stenting) and clinical patency (no restenosis or TLR) at 1 year. The Kaplan-Meier method was employed to evaluate time-to-event endpoints; estimates are given with 95% confidence interval (CI). RESULTS: Bailout stenting was required in 6 of 60 limbs (10%). There were no stent fractures or deformities after atherectomy + adjunctive angioplasty reported by the core laboratory. Kaplan-Meier estimates of freedom from TLR at 6 months and 1 year were 79.3% (95% CI 68.9% to 89.8%) and 60.7% (95% CI 47.8% to 73.6%), respectively. When bailout stenting at the index procedure was not considered a TLR event, freedom from TLR estimates at 6 months and 1 year were 89.3% (95% CI 81.2% to 97.4%) and 66.8% (95% CI 54.3% to 74.2%), respectively. Clinical patency rates at 6 months and 1 year were 77.5% (31/40) and 51.7% (15/29), respectively. CONCLUSION: JetStream atherectomy using the XC device and no drug-eluting devices is feasible, with good clinical patency and 1-year freedom from TLR